Evidence map›Paper›PMID 30092031›Full record

ArticlePloS one2018

Distinct amino acid motifs carrying multiple positive charges regulate membrane targeting of dysferlin and MG53.

Lu Zhou, Volker Middel, Markus Reischl, Uwe Strähle, G Ulrich Nienhaus

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances in the Study of MG53 in Cardiovascular Disease.International journal of general medicine · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Lu ZhouInstitute of Applied Physics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Volker MiddelInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Markus ReischlInstitute for Applied Computer Science, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
Uwe SträhleInstitute of Toxicology and Genetics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
G Ulrich NienhausInstitute of Applied Physics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.ORCID 0000-0002-5027-3192
Karlsruhe Institute of Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysferlin (Dysf) and mitsugumin53 (MG53) are two key proteins involved in membrane repair of muscle cells which are efficiently recruited to the sarcolemma upon lesioning. Plasma membrane localization and recruitment of a Dysf fragment to membrane lesions in zebrafish myofibers relies on the presence of a short, polybasic amino acid motif, WRRFK. Here we show that the positive charges carried by this motif are responsible for this function. In mouse MG53, we have identified a similar motif with multiple basic residues, WKKMFR. A single amino acid replacement, K279A, leads to severe aggregation of MG53 in inclusion bodies in HeLa cells. This result is due to the loss of positive charge, as shown by studying the effects of other neutral amino acids at position 279. Consequently, our data suggest that positively charged amino acid stretches play an essential role in the localization and function of Dysf and MG53.

Indexed as

Amino Acid MotifsAmino AcidsAnimalsCarrier ProteinsCell MembraneDysferlinHeLa CellsHumansMiceMicroscopy, ConfocalMuscle ProteinsMuscle, SkeletalMutationProtein BindingProtein DomainsSarcolemmaAmino AcidsCarrier ProteinsDysferlinDYSF protein, humanMuscle ProteinsTRIM72 protein, humanTripartite Motif ProteinsTryptophan

Identifiers

PMID30092031
PMCPMC6084962
OpenAlexW2887556572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.